Cost-Effectiveness of Edoxaban Compared with Dalteparin for the Treatment of Cancer-Associated Venous Thromboembolism
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1463
https://www.valueinhealthjournal.com/article/S1098-3015(18)31769-8/fulltext
Title :
Cost-Effectiveness of Edoxaban Compared with Dalteparin for the Treatment of Cancer-Associated Venous Thromboembolism
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31769-8&doi=10.1016/j.jval.2018.04.1463
First page :
Section Title :
Open access? :
No
Section Order :
710